Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 68071-3701

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 68071-3701). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 3701 9)

Label for Atorvastatin Calcium 10 mg film-coated tablets from NuCare Pharmaceuticals, Inc. The package contains 90 tablets. The label includes NDC 68071-3701-9 and states that each tablet contains 10 mg Atorvastatin Calcium equivalent to 10.825 mg Atorvastatin Calcium Trihydrate, USP. It is marked Rx Only with instructions to keep out of reach of children and store at controlled temperature (68-77°F).*

FDA Label Image

Atorvastatinfigure1. (Atorvastatinfigure1)

Chemical structure of atorvastatin calcium dihydrate, showing the molecular arrangement of atoms including phenyl rings and fluorophenyl group, with calcium ion and water molecules indicated.*

FDA Label Image

Atorvastatinfigure2. (Atorvastatinfigure2)

A line graph depicting cumulative incidence (%) over a period of 3.5 years, comparing Atorvastatin and placebo groups. The x-axis represents time in years, while the y-axis shows cumulative incidence percentages, with Atorvastatin showing a lower incidence than placebo throughout the period.*

FDA Label Image

Atorvastatinfigure3. (Atorvastatinfigure3)

A line graph comparing cumulative hazard percentages over five years between placebo and atorvastatin groups, showing lower cumulative hazard for atorvastatin. The x-axis represents time to the first primary endpoint through four years of follow-up, and the y-axis shows cumulative hazard percentage. Hazard ratio (HR) and p-value are displayed on the graph.*

FDA Label Image

Atorvastatinfigure4. (Atorvastatinfigure4)

A line graph showing the time to the first major cardiovascular endpoint over a 5-year period for Atorvastatin 10 mg and 80 mg. The vertical axis represents the percentage of subjects experiencing the endpoint, with 10 mg having a higher event curve than 80 mg. The graph includes a hazard ratio (HR 0.78) with confidence interval and p-value indicating statistical significance.*

FDA Label Image

Atorvastatinfigure9 (Atorvastatinfigure9)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.